EBOS Group logo

Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy EBOS Group shares (EBO)

Learn how to easily invest in EBOS Group shares on the NZX.

EBOS Group markets, wholesales and distributes a wide range of healthcare and pharmaceutical products. If you’d like to invest in the company, EBOS Group shares (EBO) are listed on the New Zealand Exchange (NZX) as well as in Australia. Keep reading to find out how to buy them.

How to buy shares in EBOS Group on the New Zealand Exchange

  1. Compare share trading platforms. If you’re a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table. Most importantly, you need to find a share trading platform that allows you to trade on the NZX.
  2. Open and fund your share trading account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
  3. Search for EBOS Group. Find the stock by name or ticker symbol: EBO. Research its history to confirm it’s a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until EBOS Group reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. Weigh your budget against a diversified portfolio that can minimise risk through the market’s ups and downs. You may be able to buy a fractional share of EBOS Group, depending on your share trading account.
  6. Check in on your investment. Congratulations, you own a part of EBOS Group. Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Compare NZX share trading platforms

1 - 4 of 4
Name Product Available Investment Types Min. Monthly Fee Available Markets
BlackBull Markets Share Trading
US, NZ, AU, Funds with exposure to multiple markets
Exclusive: Sign up through Finder and get 5 free shares with a minimum first time deposit of $1,000. T&Cs apply.
Trade 23,000+ shares and access 80+ global markets across the US, New Zealand, Australia and more, plus benefit from extended trading hours, no monthly fees, 24/6 dedicated local support and a mobile trading app available on both Android and iOS.
Shares, ETFs, Managed Funds, Index Funds
US, NZ, AU, Funds with exposure to multiple markets
Trade and invest in more than 8,000 companies, ETFs and managed funds across New Zealand, the US and Australia.
ASB Securities
Shares, ETFs, Bonds
NZ, AU, Funds with exposure to multiple markets
Direct Broking
Shares, ETFs, Bonds
$5 per month
NZ, AU, Funds with exposure to multiple markets

Compare up to 4 providers

EBOS Group overview and background

EBOS Group Limited can trace its history back to the founding of Early Brothers Trading Co. Ltd in Christchurch in 1922. Renamed Early Bros Dental & Surgical Supplies Ltd in the 1950s, the company became EBOS Group in 1986. It obtained a Top 50 listing on the NZX in 2006 and has continued to expand its business through a wide range of acquisitions.

Today, EBOS markets itself as the largest marketer, wholesaler and distributor of healthcare, medical and pharmaceutical products in Australasia. Headquartered in Docklands in the Australian state of Victoria, the company employs over 3,700 people in 60+ locations throughout Australasia.

EBOS Group shares are listed on the NZX as well as on the Australian Securities Exchange (ASX).

Performance and company results

In its 2020 annual report, EBOS Group Limited announced the following key results:

  • Revenue of $8.8 billion (an increase of 26.5%)
  • Reported net profit after tax of $162.5 million (an increase of 18%)
  • Underlying EBITDA of $296.6 million (an increase of 13.4%)
  • Dividend per share of 77.5 cents (increase of 8.4%)
  • Net investment in capital works of $28.9 million
  • Acquisition investment spend of $44.6 million

Key details

NameEbos Group LimitedIndustryMedical Distribution
Ticker symbolEBOISINNZEBOE0001S6
TypeOrdinary sharesDate listed on NZX01 Dec 1960
End of financial yearJuneChief executive officerJohn Cullity
Disclaimer: This information should not be interpreted as an endorsement of stocks, ETFs or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Stocks and ETFs trading involves substantial risk of loss and therefore are not appropriate for all investors. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More guides on Finder

Go to site